Log In
Print
BCIQ
Print
Print this Print this
 

EP-AD Diagnostic CSF Test

  Manage Alerts
Collapse Summary General Information
Company Amorfix Life Sciences Ltd.
DescriptionUltrasensitive assay that uses Epitope Protection technology for detecting aggregated beta amyloid
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationNeurology, Diagnostic
Indication DetailsDiagnose Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today